Capital Efficiency: It’s not about spending less — it’s about creating value faster

For over 30 years we at PharmaVentures have seen the ebbs and flows of venture capital funding into emerging biotech companies. In today’s tight funding environment capital efficiency is again in the forefront of investor and company executive thoughts.

The paper examines how companies can optimise financing strategy, accelerate value creation, and position themselves more effectively for partnering and investment.